Biomedical Engineering Reference
In-Depth Information
11. OVRUM E, TANGEN G, OYSTESE R, RINGDAL MAL, ISTAD R (2001), 'Comparison of
two heparin coated extracorporeal circuits with reduced systemic anticoagula-
tion in routine coronary artery bypass operations', J Thorac Cardiovasc Surg ,
121 , 324-330.
12. VIDEM V, MOLLNES TE, FOSSE E et al. (1999) , 'Heparin coated cardiopulmonary
bypass equipment: biocompatibility markers and development of complications
in a high risk population', J Thorac Cardiovasc Surg , 117 , 794-802.
13. GUNAYDIN S (2004), 'Emerging technologies in biocompatible surface modifying
additives: quest for physiologic cardiopulmonary bypass', Curr Med Chem Car-
diovascular & Hematologic Agents , 2 , 187-196.
14. GUNAYDIN S, MCCUSKER K, VIJAY V (2005), 'Clinical performance and biocompat-
ibility of novel hyaluronan-based heparin-bonded extracorporeal circuits',
J Extra Corpor Technol , 37 (3), 290-295.
15. GUNAYDIN S, FARSAK B, KOCAKULAK M, SARI T, YORGANCIOGLU C,
ZORLUTUNA Y (2002), 'Clinical performance and biocompatibility of poly(2-
methoxyethylacrylate) coated extracorporeal circuits', Ann Thorac Surg , 74 (3),
819-824.
16. GUNAYDIN S (2004), 'Clinical signifi cance of coated extracorporeal circuits: a
review of novel technologies', Perfusion , 19 , S33-S41.
17. GUNAYDIN S, MCCUSKER K, VIJAY V et al. (2006), 'Comparison of polymethoxyeth-
ylacrylate-coated circuits with leukocyte fi ltration and reduced heparinization
protocol on heparin-bonded circuits in different risk cohorts', Perfusion , 21 (6),
329-342.
18. SOCIETY OF THORACIC SURGEONS BLOOD CONSERVATION GUIDELINE TASK FORCE,
FERRARIS VA, FERRARIS SP, SAHA SP et al. (2007), 'Perioperative blood transfusion
and blood conservation in cardiac surgery: the Society of Thoracic Surgeons
and The Society of Cardiovascular Anesthesiologists clinical practice guideline',
Ann Thorac Surg , 83 (5 Suppl), S27-86.
19. MULHOLLAND JW, ANDERSON JR, YARHAM GJ, TULADHUR S, SAED I, OLIVER MD (2007),
'Miniature cardiopulmonary bypass - the Hammersmith experience', Perfusion ,
22 , 161-166. DOI: 10.1177/0267659107076880.
20. KUTSCHKA I, SCHÖNROCK U, EL ESSAWI A, PAHARI D, ANSSAR M, HARRINGER W (2007),
'A new minimized perfusion circuit provides highly effective ultrasound con-
trolled deairing', Artifi cial Organs , 31 (3), 215-220.
21. GUNAYDIN S, AYRANCIOGLU K, DIKMEN E et al. (2007), 'Clinical effects of leukofi l-
tration and surface modifi cation on post-cardiopulmonary bypass atrial fi brilla-
tion in different risk cohorts', Perfusion , 22 (4), 279-288.
22. GUNAYDIN S, MCCUSKER K, VIJAY V (2005), 'Strategic leukofi ltration in cardiac
surgery', Curr Med Chem , 3 , 173-179.
23. GUNAYDIN S, SARI T, MCCUSKER K et al. (2005), 'Clinical evaluation strategic
leukofi ltration with surface modifi cation: enhanced preservation or fantasy',
Filtration , 1 (1), 57-67.
24. GUNAYDIN S, MCCUSKER K, VIJAY V et al. (2005), 'Clinical signifi cance of strategic
leukocyte fi ltration in different risk cohorts undergoing cardiac surgery', Filtra-
tion , 1 (2), 95-106.
￿ ￿ ￿ ￿ ￿
Search WWH ::




Custom Search